Immunovant (IMVT) COO sells 17,714 shares, keeps 224,393 stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Immunovant, Inc. Chief Operating Officer Gloria Melanie reported open-market sales of a total of 17,714 shares of common stock. The shares were sold in two transactions at weighted average prices of $38.18 and $38.95 per share, within disclosed intraday price ranges.
After these sales, she directly holds 224,393 shares of Immunovant common stock, indicating she retains a substantial equity position despite the net reduction.
Positive
- None.
Negative
- None.
Insights
COO executes modest open-market sale, retains large stake.
Chief Operating Officer Gloria Melanie executed two open-market sales totaling 17,714 shares of Immunovant common stock at weighted average prices of $38.18 and $38.95 per share. These are straightforward discretionary dispositions, not option exercises or tax withholdings.
Following the transactions, she directly holds 224,393 shares, so the sale represents a relatively small portion of her visible stake. With no remaining derivatives listed and no 10b5-1 or similar language in the excerpt, this appears as a routine portfolio move based solely on the information provided.
Insider Trade Summary
Net Seller: 17,714 shares ($678,604)
Net Sell
2 txns
Insider
Gloria Melanie
Role
Chief Operating Officer
Sold
17,714 shs ($679K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 14,748 | $38.18 | $563K |
| Sale | Common Stock | 2,966 | $38.95 | $116K |
Holdings After Transaction:
Common Stock — 227,359 shares (Direct, null)
Footnotes (1)
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.77 - $38.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.78 - $39.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Key Figures
Shares sold (total): 17,714 shares
First sale size: 2,966 shares
First sale price: $38.95 per share
+5 more
8 metrics
Shares sold (total)
17,714 shares
Open-market sales of common stock
First sale size
2,966 shares
Common Stock, open-market sale
First sale price
$38.95 per share
Weighted average sale price
Second sale size
14,748 shares
Common Stock, open-market sale
Second sale price
$38.18 per share
Weighted average sale price
Holdings after transactions
224,393 shares
Directly owned common stock after sales
Lower price range
$37.77–$38.56
Detailed execution range for one sale
Higher price range
$38.78–$39.13
Detailed execution range for other sale
Key Terms
open-market sale, weighted average price, Common Stock, Form 4, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"within the range set forth in this footnote to this Form 4."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
direct ownership financial
"ownership_type": "direct""
FAQ
What insider activity did Immunovant (IMVT) report for its COO?
Immunovant reported that COO Gloria Melanie sold 17,714 shares of common stock in open-market transactions. The trades occurred at weighted average prices of about $38 per share, while she retained a substantial remaining direct holding after the sales.
Do the Immunovant (IMVT) Form 4 footnotes show exact sale prices for each trade?
The footnotes state that each transaction’s reported price is a weighted average, with actual trades executed in ranges of $37.77–$38.56 and $38.78–$39.13. The insider offers to provide detailed, price-by-price information upon request.